Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2013 Financial Results and HCV Pipeline Update on Wedn...
29 October 2013 - 7:05AM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that the
Company's third quarter 2013 financial results will be released
after close of market on Wednesday, October 30, 2013.
Idenix management will host a conference call at 4:30 p.m. ET on
Wednesday, October 30, 2013, to discuss the Company's financial
results for the third quarter of 2013 and provide an update on the
Company's development programs.
To access the call, please dial (877) 640-9809 (U.S./Canada) or
(914) 495-8528 (International) and enter passcode 90503423. A
live webcast will be available via the Investor section of the
Idenix website at www.idenix.com under "Events &
Presentations". The archived webcast will be available for
two weeks following the call on the Idenix website.
ABOUT IDENIX
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical Company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of
patients with hepatitis C infection. For further information
about Idenix, please refer to www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Teri Dahlman
(617) 995-9807
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More News Articles